Closing Price ($) | Shares Out (MM) | Market Cap ($MM) |
$151.45 | 60 | $9,038 |
10-Q | 2019-09-30 | Quarter: 2019-09-30 |
10-Q | 2019-06-30 | Quarter: 2019-06-30 |
10-Q | 2019-03-31 | Quarter: 2019-03-31 |
10-K | 2018-12-31 | Annual: 2018-12-31 |
10-Q | 2018-09-30 | Quarter: 2018-09-30 |
10-Q | 2018-06-30 | Quarter: 2018-06-30 |
10-Q | 2018-03-31 | Quarter: 2018-03-31 |
10-K | 2017-12-31 | Annual: 2017-12-31 |
10-Q | 2017-09-30 | Quarter: 2017-09-30 |
10-Q | 2017-06-30 | Quarter: 2017-06-30 |
10-Q | 2017-03-31 | Quarter: 2017-03-31 |
10-K | 2016-12-31 | Annual: 2016-12-31 |
10-Q | 2016-09-30 | Quarter: 2016-09-30 |
10-Q | 2016-06-30 | Quarter: 2016-06-30 |
10-Q | 2016-03-31 | Quarter: 2016-03-31 |
10-K | 2015-12-31 | Annual: 2015-12-31 |
10-Q | 2015-09-30 | Quarter: 2015-09-30 |
10-Q | 2015-06-30 | Quarter: 2015-06-30 |
10-Q | 2015-03-31 | Quarter: 2015-03-31 |
10-K | 2014-12-31 | Annual: 2014-12-31 |
10-Q | 2014-09-30 | Quarter: 2014-09-30 |
10-Q | 2014-06-30 | Quarter: 2014-06-30 |
10-Q | 2014-03-31 | Quarter: 2014-03-31 |
10-K | 2013-12-31 | Annual: 2013-12-31 |
8-K | 2019-11-05 | Earnings, Exhibits |
8-K | 2019-09-16 | Other Events |
8-K | 2019-09-06 | Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits |
8-K | 2019-09-04 | Regulation FD, Exhibits |
8-K | 2019-09-03 | Regulation FD, Exhibits |
8-K | 2019-08-05 | Earnings, Exhibits |
8-K | 2019-07-31 | Exhibits |
8-K | 2019-05-30 | Exhibits |
8-K | 2019-05-02 | Earnings, Exhibits |
8-K | 2019-04-29 | Officers |
8-K | 2019-02-25 | Earnings, Exhibits |
8-K | 2019-01-25 | Regulation FD, Exhibits |
8-K | 2019-01-25 | Regulation FD, Exhibits |
8-K | 2019-01-03 | Earnings, Exhibits |
8-K | 2018-11-01 | Earnings, Exhibits |
8-K | 2018-10-16 | Officers, Exhibits |
8-K | 2018-09-10 | Regulation FD, Exhibits |
8-K | 2018-08-02 | Earnings, Exhibits |
8-K | 2018-06-29 | Enter Agreement |
8-K | 2018-05-16 | Shareholder Vote |
8-K | 2018-05-07 | Enter Agreement, Leave Agreement, Shareholder Rights, Amend Bylaw, Exhibits |
8-K | 2018-05-03 | Earnings, Exhibits |
8-K | 2018-04-27 | Exhibits |
8-K | 2018-02-21 | Earnings, Exhibits |
Comps ($MM TTM) | Market Cap | Assets | Liabilities | Revenue | Gross Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|
Dexcom (DXCM) | 12,908 | 2,066 | 1,378 | 1,222 | 767 | -170 | -87 | 12,198 |
Dentsply Sirona (XRAY) | 13,003 | 8,575 | 3,392 | 0 | 2,041 | 105 | 478 | 14,194 |
Insulet (PODD) | 7,136 | 978 | 728 | 661 | 435 | 17 | 47 | 7,624 |
Novocure (NVCR) | 5,679 | 406 | 247 | 294 | 212 | -41 | -16 | 5,646 |
Abiomed (ABMD) | 11,806 | 1,125 | 122 | 797 | 661 | 258 | 327 | 11,705 |
Hill-Rom Holdings (HRC) | 7,067 | 4,575 | 2,951 | 2,884 | 1,415 | 215 | 335 | 8,663 |
Haemonetics (HAE) | 6,085 | 1,260 | 669 | 727 | 450 | 49 | 176 | 6,331 |
Globus Medical (GMED) | 4,300 | 1,391 | 103 | 743 | 573 | 143 | 221 | 4,182 |
Integra Lifesciences (IART) | 4,669 | 3,290 | 1,869 | 1,493 | 930 | 101 | 262 | 5,393 |
Penumbra (PEN) | 6,047 | 585 | 131 | 495 | 332 | 15 | 23 | 5,969 |
Tandem Diabetes Care (TNDM) | 3,601 | 255 | 110 | 282 | 147 | -55 | -49 | 3,470 |
Cantel Medical (CMD) | 3,630 | 1,070 | 409 | 0 | 427 | 55 | 126 | 3,816 |
ICU Medical (ICUI) | 5,345 | 1,623 | 305 | 1,311 | 508 | 47 | 127 | 5,031 |
Nuvasive (NUVA) | 3,283 | 1,805 | 1,127 | 814 | 52 | 194 | 3,765 | |
Nevro (NVRO) | 1,957 | 448 | 246 | 379 | 261 | -93 | -77 | 2,049 |
Glaukos (GKOS) | 2,779 | 302 | 114 | 211 | 182 | -12 | -7 | 2,730 |
Merit Medical Systems (MMSI) | 3,357 | 1,736 | 786 | 949 | 423 | 39 | 141 | 3,722 |
iRhythm Technologies (IRTC) | 1,941 | 207 | 159 | 182 | 137 | -44 | -40 | 1,923 |
Cardiovascular Systems (CSII) | 1,490 | 219 | 71 | 248 | 200 | -0 | 4 | 1,416 |
Inspire Medical Systems (INSP) | 1,451 | 186 | 33 | 64 | 52 | -25 | -23 | 1,424 |
Balance Sheet ($MM) | 2011-12-31 | 2012-03-31 | 2012-06-30 | 2012-09-30 | 2012-12-31 | 2013-03-31 | 2013-06-30 | 2013-09-30 | 2013-12-31 | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Cash | 94 | 83 | 70 | 63 | 57 | 148 | 151 | 154 | 150 | 146 | 176 | 146 | 151 | 146 | 145 | 145 | 123 | 112 | 76 | 215 | 137 | 76 | 73 | 102 | 273 | 203 | 136 | 127 | 114 | 129 | 120 |
Accounts Receivable | 23 | 26 | 26 | 30 | 33 | 31 | 34 | 34 | 33 | 37 | 42 | 47 | 40 | 36 | 32 | 32 | 48 | 40 | 39 | 39 | 29 | 41 | 38 | 47 | 53 | 50 | 50 | 70 | 63 | 69 | 67 |
Inventory | 12 | 15 | 16 | 15 | 15 | 9 | 6 | 5 | 9 | 10 | 9 | 10 | 13 | 20 | 23 | 13 | 14 | 14 | 24 | 33 | 36 | 34 | 34 | 35 | 34 | 26 | 41 | 58 | 71 | 74 | 85 |
PP&E | 42 | 20 | 21 | 25 | 53 | 25 | 29 | 31 | 67 | 33 | 34 | 37 | 60 | 45 | 42 | 42 | 70 | 42 | 41 | 51 | 88 | 65 | 76 | 88 | 159 | 153 | 198 | 229 | 324 | 300 | 334 |
Assets | 210 | 204 | 192 | 192 | 198 | 281 | 286 | 289 | 288 | 289 | 325 | 301 | 302 | 306 | 300 | 293 | 275 | 255 | 263 | 453 | 457 | 445 | 459 | 500 | 817 | 830 | 839 | 886 | 929 | 953 | 978 |
Accounts Payable | 11 | 16 | 14 | 16 | 9 | 9 | 11 | 15 | 19 | 21 | 19 | 18 | 15 | 14 | 18 | 16 | 19 | 13 | 22 | 18 | 13 | 6 | 12 | 29 | 24 | 34 | 25 | 27 | 26 | 27 | 25 |
Long-Term Debt | |||||||||||||||||||||||||||||||
Liabilities | 138 | 145 | 144 | 153 | 154 | 151 | 148 | 168 | 163 | 166 | 242 | 221 | 218 | 225 | 230 | 238 | 241 | 228 | 236 | 388 | 393 | 381 | 395 | 426 | 658 | 659 | 660 | 688 | 717 | 729 | 728 |
Stockholders' Equity | 71 | 59 | 48 | 39 | 44 | 130 | 138 | 121 | 125 | 122 | 78 | 80 | 84 | 81 | 70 | 55 | 34 | 26 | 27 | 65 | 63 | 64 | 65 | 74 | 159 | 171 | 179 | 198 | 212 | 224 | 250 |
Income Statement ($MM) | 2011-12-31 | 2012-03-31 | 2012-06-30 | 2012-09-30 | 2012-12-31 | 2013-03-31 | 2013-06-30 | 2013-09-30 | 2013-12-31 | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Revenue | 47 | 48 | 52 | 55 | 58 | 57 | 60 | 61 | 69 | 69 | 80 | 75 | 73 | 61 | 76 | 87 | 100 | 81 | 87 | 95 | 104 | 102 | 110 | 122 | 131 | 124 | 124 | 151 | 165 | 160 | 186 |
Cost of Revenue | 27 | 27 | 29 | 30 | 33 | 32 | 33 | 34 | 36 | 36 | 36 | 37 | 36 | 28 | 41 | 52 | 55 | 37 | 37 | 39 | 43 | 42 | 45 | 48 | 51 | 48 | 42 | 49 | 55 | 53 | 61 |
Gross Profit | 20 | 20 | 23 | 24 | 25 | 25 | 27 | 27 | 33 | 33 | 41 | 38 | 37 | 33 | 34 | 36 | 45 | 44 | 50 | 56 | 61 | 59 | 65 | 74 | 80 | 76 | 82 | 102 | 110 | 107 | 116 |
R&D | 5 | 7 | 7 | 4 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 12 | 10 | 13 | 13 | 13 | 14 | 16 | 18 | 18 | 20 | 19 | 20 | 18 | 22 | 29 | 32 | 32 | ||
SG&A | 26 | 26 | 26 | 27 | 27 | 39 | 26 | 28 | 34 | 34 | 32 | 33 | 35 | 41 | 56 | 39 | 39 | 39 | 49 | 47 | 50 | 51 | 61 | 56 | 59 | 73 | 66 | 67 | 77 | ||
Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 0 | 0 | ||
Net Income | -14 | -15 | -14 | -12 | -10 | -11 | -11 | -21 | -2 | -6 | -14 | -11 | -5 | -12 | -15 | -19 | -27 | -12 | -4 | -3 | -9 | -10 | -8 | -2 | -7 | -7 | -2 | 2 | 10 | 4 | 1 |
Cash Flow ($MM) | 2011-12-31 | 2012-03-31 | 2012-06-30 | 2012-09-30 | 2012-12-31 | 2013-03-31 | 2013-06-30 | 2013-09-30 | 2013-12-31 | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Cash Operating | -9 | -11 | -3 | -1 | 4 | 4 | -4 | -1 | 1 | 5 | 5 | -3 | 1 | 9 | -19 | -11 | 4 | 3 | 20 | -22 | 18 | 23 | 22 | -4 | -6 | 16 | 30 | 6 | 14 | ||
Cash Investing | -2 | -3 | -5 | -1 | -2 | -2 | -3 | -2 | -4 | -3 | -3 | -4 | -0 | -7 | -3 | 1 | -37 | -45 | -97 | -42 | -22 | 3 | -149 | -56 | -61 | -27 | -41 | 8 | -39 | ||
Cash Financing | -0 | 1 | 1 | 93 | 0 | 1 | 2 | -1 | 33 | -31 | 3 | 2 | -1 | -1 | -1 | -2 | -2 | 182 | -1 | 3 | 1 | 2 | 298 | -9 | 1 | 1 | -2 | 2 | 16 |